New SEC Form D filing

HCW Biologics Inc., 2026-10-08

A new SEC Form D private-offering notice from Miramar, FL, a $1,500,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

HCW Biologics Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing immunotherapies targeting chronic inflammation and age-related disease, using its TOBI fusion-protein discovery platform.

Filed 2026-10-08Filed to raise $1,500,000First money in 2026-09-24Raised so far $1,500,000HQ (as filed) Miramar, FLSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified hcwbiologics.com↗Named in the filing 7 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source